Forgot your log-in info?
Fred’s Team is Memorial Sloan Kettering’s (MSK) athletic fundraising program dedicated to bringing us closer to a world without cancer. Our official events include the TCS NYC Marathon, the Boston Marathon, and the NYC Half. You can also participate in any race through our Choose Your Own Event program. Fred’s Team provides exclusive benefits for both our official events and our Choose Your Own Event program, giving each participant an unbeatable experience in their effort to cross the finish line. The race against cancer is personal—when you participate with Fred’s Team, the money you raise supports the area of research of your choice at MSK.Learn More
“Fred’s Team has played an important role in two areas: one is support of seed projects to explore new ideas and ways to fight cancer, and the other is better developed approaches to clinical trials.”
—Dr. Richard O’Reilly, Chair of the Department of Pediatrics at MSKCC
Since 1995, Fred’s Team has raised over $56 million. The money the program raises goes directly to Memorial Sloan Kettering, which not only improves cancer research and care at MSK, but also helps spark progress at centers worldwide that look to our institution to set the standard of achievement and pace of innovation.
The money raised by Fred’s Team participants supports over 50 areas of cancer research —including bladder, brain, breast, colon, colorectal, head and neck, kidney, leukemia, liver, lung, lymphoma, melanoma, multiple myeloma, neuroblastoma, ovarian, pancreatic, prostate, testicular, rare cancers and The Aubrey Fund for Pediatric Cancer Research.
The Aubrey Fund for Pediatric Cancer Research
Since 1997, Fred’s Team has been the primary source of support for the Aubrey Fund, which funds ongoing research on childhood cancers, including leukemia, neuroblastoma, brain tumors and certain forms of sarcoma.
The fund is named for Aubrey Barr, who as a young girl received experimental treatment for acute lymphoblastic leukemia at MSK. She was pronounced cancer-free at a time when the survival rate for the disease was just one in ten.
“I was only four years old, life expectancy was just six months, and the survival rate was roughly 10%. My parents brought me to MSK—there were no answers, just hope. The fourth protocol developed and administered by MSK finally cured my disease. It is the one that hospitals still use today to save the lives of more than 80% of patients like me.”
—Aubrey Barr, Fred’s Team runner and pediatric cancer survivor